Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Response to 'In-utero exposure to tenofovir is associated with impaired fetal and infant growth' by Denneman et al.

le Roux SM, Abrams EJ, Jao J, Malaba T, Myer L.

AIDS. 2017 Feb 20;31(4):595-596. doi: 10.1097/QAD.0000000000001338. No abstract available.

PMID:
28118235
2.

Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants.

M le Roux S, Jao J, Brittain K, Phillips TK, Olatunbosun S, Ronan A, Zerbe A, Abrams EJ, Myer L.

AIDS. 2017 Jan 2;31(1):97-104.

PMID:
27898591
3.

Tenofovir exposure in utero and linear growth in HIV exposed, uninfected infants: a prospective study.

M le Roux S, Jao J, Brittain K, Phillips TK, Olatunbosun S, Ronan A, Zerbe A, Abrams EJ, Myer L.

AIDS. 2016 Oct 14. [Epub ahead of print]

PMID:
27755111
4.

Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?

Jao J, Hazra R, Mellins CA, Remien RH, Abrams EJ.

J Int AIDS Soc. 2016 Oct 13;19(1):21099. doi: 10.7448/IAS.19.1.21099. eCollection 2016 Oct 13.

5.

Severe Vitamin D Deficiency in Human Immunodeficiency Virus-Infected Pregnant Women is Associated with Preterm Birth.

Jao J, Freimanis L, Mussi-Pinhata MM, Cohen RA, Monteiro JP, Cruz ML, Branch A, Sperling RS, Siberry GK; NISDI LILAC Protocol..

Am J Perinatol. 2017 Apr;34(5):486-492. doi: 10.1055/s-0036-1593536. Epub 2016 Oct 7.

PMID:
27716863
6.

In Utero Tenofovir Exposure Is not Associated With Fetal Long Bone Growth.

Jao J, Abrams EJ, Phillips T, Petro G, Zerbe A, Myer L.

Clin Infect Dis. 2016 Jun 15;62(12):1604-9. doi: 10.1093/cid/ciw159. Epub 2016 Mar 23.

PMID:
27009251
7.

Prediabetes and diabetes among HIV-infected adults in Cameroon.

Rhee JY, Bahtila TD, Palmer D, Tih PM, Aberg JA, LeRoith D, Jao J.

Diabetes Metab Res Rev. 2016 Sep;32(6):544-9. doi: 10.1002/dmrr.2792. Epub 2016 Apr 6.

PMID:
26891253
8.

Retrospective analysis of the prevalence of and factors associated with condom use among young HIV-infected women in Cameroon.

Pilapil M, Morris L, Saito K, Kouya F, Maku V, Kwalar R, Palmer N, Tih PM, Jao J.

SAGE Open Med. 2016 Jan 14;4:2050312115626432. doi: 10.1177/2050312115626432. eCollection 2016 Jan 14.

9.

In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana.

Powis KM, Smeaton L, Hughes MD, Tumbare EA, Souda S, Jao J, Wirth KE, Makhema J, Lockman S, Fawzi W, Essex M, Shapiro RL.

AIDS. 2016 Jan;30(2):211-20. doi: 10.1097/QAD.0000000000000895.

10.

Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.

Jao J, Kirmse B, Yu C, Qiu Y, Powis K, Nshom E, Epie F, Tih PM, Sperling RS, Abrams EJ, Geffner ME, LeRoith D, Kurland IJ.

J Clin Endocrinol Metab. 2015 Sep;100(9):3260-9. doi: 10.1210/JC.2015-2198. Epub 2015 Jul 2.

11.

Low vitamin D status among pregnant Latin American and Caribbean women with HIV Infection.

Jao J, Freimanis L, Mussi-Pinhata MM, Cohen RA, Monteiro JP, Cruz ML, Sperling RS, Branch A, Siberry GK; NISDI LILAC Protocol..

Int J Gynaecol Obstet. 2015 Jul;130(1):54-8. doi: 10.1016/j.ijgo.2015.01.017. Epub 2015 Apr 11.

12.

Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults.

Morris LE, Posada R, Hickman CJ, Latner DR, Singh TA, Rautenberg A, Jao J, Bellini WJ, Sperling R.

J Pediatric Infect Dis Soc. 2015 Mar;4(1):63-6. doi: 10.1093/jpids/pit054. Epub 2013 Sep 24.

13.

Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, or Enfuvirtide in Highly Treatment-Experienced Perinatally Infected Pregnant Women.

Shust GF, Jao J, Rodriguez-Caprio G, Posada R, Chen KT, Averitt A, Sperling RS.

J Pediatric Infect Dis Soc. 2014 Sep;3(3):246-50. doi: 10.1093/jpids/pit019. Epub 2013 Apr 12.

14.

Growth patterns in the first year of life differ in infants born to perinatally vs. nonperinatally HIV-infected women.

Jao J, Agwu A, Mhango G, Kim A, Park K, Posada R, Abrams EJ, Hutton N, Sperling RS.

AIDS. 2015 Jan 2;29(1):111-6. doi: 10.1097/QAD.0000000000000501.

15.

Factors associated with inconsistent condom use in adolescents with negative or unknown HIV status in Northwest Cameroon.

Morris L, Kouya F, Kwalar R, Pilapil M, Saito K, Palmer N, Posada R, Tih PM, Welty T, Jao J.

AIDS Care. 2014;26(11):1440-5. doi: 10.1080/09540121.2014.920948. Epub 2014 May 27.

16.

Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis.

Ford N, Shubber Z, Jao J, Abrams EJ, Frigati L, Mofenson L.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):512-21. doi: 10.1097/QAI.0000000000000211. Review.

17.

Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants.

Jao J, Abrams EJ.

Pediatr Infect Dis J. 2014 Jul;33(7):734-40. doi: 10.1097/INF.0000000000000224. Review.

18.

Gestational diabetes mellitus in HIV-infected and -uninfected pregnant women in Cameroon.

Jao J, Wong M, Van Dyke RB, Geffner M, Nshom E, Palmer D, Muffih PT, Abrams EJ, Sperling RS, Leroith D.

Diabetes Care. 2013 Sep;36(9):e141-2. doi: 10.2337/dc13-0968. No abstract available.

19.

Small for gestational age birth outcomes in pregnant women with perinatally acquired HIV.

Jao J, Sigel KM, Chen KT, Rodriguez-Caprio G, Posada R, Shust G, Wisnivesky J, Abrams EJ, Sperling RS.

AIDS. 2012 Apr 24;26(7):855-9. doi: 10.1097/QAD.0b013e328351f6ef.

20.

Prevalence and predictors of proteinuria in HIV-infected and uninfected pregnant women in Cameroon.

Jao J, Palmer D, Leus I, Tih P, Baweja M, Klotman M, Sperling R, Wyatt C.

Nephrol Dial Transplant. 2011 Sep;26(9):3051-3. doi: 10.1093/ndt/gfr310. Epub 2011 Jun 30.

PMID:
21719713

Supplemental Content

Loading ...
Support Center